Security key
36322Q206
Damora Therapeutics, Inc. - Common Stock (DMRA)
CUSIP: 36322Q206
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 132,660
- Total 13F value
- $451,146
- Share change
- -9,908
- SEC-reported price per share
- $3.41
- Number of holders
- 8
- Value change
- -$30,019
- Number of buys
- 3
- Number of sells
- 5
- Shares outstanding
- 61,638,745
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
8
Top holders
9
DMRA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Damora Therapeutics, Inc. SEC filings
Damora Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36322Q206
Recent filing periods:
Ownership snapshot
Top reported holders of DMRA - Damora Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
11/15
Latest evidence
31 Mar 2025
13F
3/4/5
Lead comparable stake: 0.16%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 0.16%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
0.16%
RENAISSANCE TECHNOLOGIES LLC
0.02%
Squarepoint Ops LLC
0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.02%
Tower Research Capital LLC (TRC)
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
0.16%
|
$309,730
99,913 shares
|
— | 31 Mar 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.02%
|
$47,566
15,344 shares
|
— | 31 Mar 2025 |
| Squarepoint Ops LLC |
13F
Company
|
0.02%
|
$40,250
12,984 shares
|
— | 31 Mar 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.02%
|
$33,238
10,722 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$4,907
1,583 shares
|
— | 31 Mar 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$3,801
1,226 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
132,660
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2026 Across Filers
Q1 2026 holders
64
Q2 2025 holders
8
Holder diff
-56
| Investor | Q1 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend